Significant shareholders

As at 25 June 2018, shareholders holding more than 3% of the share capital of Tissue Regenix Group Plc are:

Name of Shareholder % of Voting Rights
Invesco Limited 28.74
Woodford Investment Management LLP 26.00
Techtran Group Limited 8.79
Baillie Gifford & Co Ltd 6.04
Jupiter Asset Management 5.88
Directors & Related Holdings 4.28
IP2IPO Limited 4.27

Shares not in public hands as at 13 February 2019 – 856,002,530 - 73%

Shares in issue as at 13 February 2019 - 1,171,730,823 ordinary shares of 0.5p each

The securities of Tissue Regenix Group plc are traded on the AIM market operated by the London Stock Exchange plc. Its shares have not been admitted, nor have any applications been made, for any of its shares to be admitted or traded on any other exchanges or trading platform.

Key Advisors

    • 150 Cheapside, 
      London, 
      EC2V 6ET 

    • Central Square,
      29 Wellington St,
      Leeds
      LS1 4DL

    • 701 Fifth Avenue, Suite 7000

      Seattle, Washington

      98104-7044

      United States

    • 4 Beckenham Rd,
      Beckenham,
      Kent 
      BR3 4TU